Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

33.85
Delayed Data
As of May 26
 -0.49 / -1.43%
Today’s Change
25.55
Today|||52-Week Range
35.04
+23.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues25.6B26.0B24.7B22.8B
 
 
 
 
 
Cost of Goods Sold3.7B4.2B3.4B3.2B
 
 
 
 
 
Depreciation And Amortization2.7B3.1B2.7B2.3B
 
 
 
 
 
 
Operating ExpensesGross Income19.2B18.6B18.6B17.3B
 
 
 
 
 
General Expenses13.1B16.1B15.0B13.8B
 
 
 
 
 
Other Operating Expenses21.9M0.000.000.00
 
 
Research And Development4.2B4.9B5.6B5.6B
 
 
 
 
 
Total Operating Expenses19.5B23.5B21.1B19.3B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.1B2.5B3.6B3.5B
 
 
 
 
 
Extraordinary Credit403.8M15.9M387.3M1.0B
 
 
 
 
 
Extraordinary Charge-3.6B-1.8B-2.1B-2.1B
 
 
 
 
 
Interest Expense On Debt411.8M416.3M391.3M612.7M
 
 
 
 
 
Equity In Earnings0.00-6.0M-16.0M-32.8M
 
 
 
 
Other Expenses710.9M887.4M1.5B1.7B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.3B1.2B3.1B3.6B
 
 
 
 
 
Income Taxes-694.0M-11.0M-242.5M-145.0M
 
 
 
 
 
Minority Interest-15.0M-2.0M-998.1K-92.4M
 
 
 
 
 
Net Income2.5B1.2B2.8B3.5B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$1.02$0.49$1.11$1.38
 
 
 
 
 
EPS Diluted$1.02$0.49$1.11$1.37